|
|
|
|
|
Detail |
| hsa-miR-100 |
|
Unspecified |
MicroRNA expression profiling in prostate cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
MicroRNA signatures in human ovarian cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
Real-time expression profiling of microRNA precursors in human cancer cell lines. |
2005 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
Expression profiling identifies microRNA signature in pancreatic cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
MicroRNAs: novel regulators involved in the pathogenesis of Psoriasis? |
2007 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. |
2008 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. |
2008 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
Distinct microRNA alterations characterize high- and low-grade bladder cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
MicroRNA expression profiles in serous ovarian carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
MicroRNA expression and identification of putative miRNA targets in ovarian cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
MicroRNA-regulated pathways associated with endometriosis. |
2009 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Unspecified |
Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. |
2009 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Causal |
Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. |
2009 |
|
|
|
|
|
|
| hsa-miR-100 |
|
Causal |
Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer |
2009 |
|
|
|
|
|
|